Chadha Ranjit S Files Form 4 for DENTSPLY SIRONA

Chadha Ranjit S 4 Filing Summary
FieldDetail
CompanyChadha Ranjit S
Form Type4
Filed DateMar 24, 2026
Risk Levellow
Pages3
Reading Time4 min
Key Dollar Amounts$65.89, $115.32, $80.08, $66.62
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: insider-activity, form-4, ownership-change

TL;DR

**Insider Chadha Ranjit S filed a Form 4, signaling a change in their DENTSPLY SIRONA holdings.**

AI Summary

This Form 4 filing, dated March 24, 2026, reports that Chadha Ranjit S, an insider at DENTSPLY SIRONA INC, has filed a statement of changes in beneficial ownership of securities. While the filing itself doesn't detail specific transactions, it indicates that an insider's holdings have changed, which is important for investors as insider activity can signal confidence or concern about the company's future. This matters to stockholders because significant insider selling might suggest a lack of confidence, while buying could signal a belief in future growth, impacting stock perception.

Why It Matters

This filing signals a change in an insider's stake, which can influence investor sentiment and potentially the stock price of DENTSPLY SIRONA INC.

Risk Assessment

Risk Level: low — This filing is purely informational and does not inherently pose a direct financial risk, but rather provides data for analysis.

Analyst Insight

A smart investor would use this filing as a trigger to investigate the specific transactions detailed within the full Form 4 document to understand if Chadha Ranjit S bought or sold shares, and then assess the potential implications for DENTSPLY SIRONA INC's stock.

Key Players & Entities

  • Chadha Ranjit S (person) — Reporting Person
  • DENTSPLY SIRONA INC (company) — Issuer of securities
  • 0001672529 (person) — Chadha Ranjit S's CIK
  • 0001225208-26-003997 (dollar_amount) — SEC Accession No.

FAQ

Who is Chadha Ranjit S?

Chadha Ranjit S is the reporting person in this Form 4 filing, indicating they are an insider at DENTSPLY SIRONA INC (CIK: 0001672529).

What company is associated with this Form 4 filing?

This Form 4 filing is associated with DENTSPLY SIRONA INC, as indicated by the mailing address and the context of the reporting person.

What is the filing date of this Form 4?

The filing date for this Form 4 is March 24, 2026, and it was accepted on the same day at 18:14:23.

What is the period of report for this Form 4?

The period of report for this Form 4 is March 20, 2026.

Where is DENTSPLY SIRONA INC's mailing address listed in the filing?

DENTSPLY SIRONA INC's mailing address is C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277.

Filing Stats: 955 words · 4 min read · ~3 pages · Grade level 7.3 · Accepted 2026-03-24 18:14:23

Key Financial Figures

  • $65.89 — the restricted stock unit exercise was $65.89. 2. Each restricted stock unit is the
  • $115.32 — tled restricted stock unit exercise was $115.32. 6. Represents the second vesting anni
  • $80.08 — tled restricted stock unit exercise was $80.08. 10. Represents the third vesting anni
  • $66.62 — tled restricted stock unit exercise was $66.62. 12. Represents the first vesting anni

Filing Documents

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Chadha Ranjit S (Last) (First) (Middle) 1902 RESTON METRO PLAZA (Street) RESTON VIRGINIA 20190 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol ICF International, Inc. [ ICFI ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) VP & Principal Accounting Off. 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/20/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common 03/20/2026 M 197 A $ 0 (1) 263 D Common 03/20/2026 M 102 A $ 0 (1) 365 D Common 03/20/2026 F 37 D $ 65.89 328 D Common 03/20/2026 F 70 D $ 65.89 258 D Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Restricted Stock Units (2) 03/20/2026 A 813 (3) (3) Common 813 $ 0.0000 2,507 D Restricted Stock Units (1) 03/20/2026 M 102 (4) (4) Common 102 (1) 2,405 D Restricted Stock Units (5) 03/20/2026 M 125 (6) (6) Common 125 (7) 2,280 D Restricted Stock Units (1) 03/20/2026 M 197 (8) (8) Common 197 (1) 2,083 D Restricted Stock Units (9) 03/20/2026 M 234 (10) (10) Common 234 (9) 1,849 D Restricted Stock Units (11) 03/20/2026 M 240 (12) (12) Common 240 (13) 1,609 D Explanation of Responses: 1. The exercise price for the restricted stock unit exercise was $65.89. 2. Each restricted stock unit is the economic equivalent of one share of ICF International, Inc.'s Common Stock. 3. These acquired restricted stock units were granted pursuant to ICF International, Inc.'s 2018 Omnibus Incentive Plan, as amended. These restricted stock units vest over a period of three (3) years, at 25% on each of the first two anniversaries of the grant and 50% on the third anniversary from the day of grant. 4. Represents the 2nd vesting anniversary (25%) of acquired restricted stock units granted pursuant to the 2018 Omnibus Incentive Plan, as amended. 5. The market value for the cash-settled restricted stock unit exercise was $115.32. 6. Represents the second vesting anniversary (25%) of acquired cash-settled restricted stock units granted pursuant to the 2010 Omnibus Plan, as amended. 7. The emarket value for the cash-settled restricted stock unit exercise was $115.32. 8. Represents the 1st vesting anniversary (25%) of acquired restricted stock units granted pursuant to the 2018 Omnibus Incentive Plan, as amended. 9. The market value for the cash-settled restricted stock unit exercise was $80.08. 10. Represents the third vesting anniversary (50%) of acquired cash-settled restricted stock units granted pursuant to the 2010 Omnibus Plan, as amended. 11. The ex

View Full Filing

View this 4 filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.